Wikidata

(Q78785334)

English

Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group

scientific article published on 01 January 2003

In more languages

Statements

title
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12525520
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12525520%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q78785334&oldid=1614831595"